Sex | Number (%) |
---|---|
Male | 8 (36%) |
Female | 14 (64%) |
Age, years | Â |
Median (range) | 67 (42-91) |
Initial treatment | Â |
Surgery alone | 8 (36%) |
Surgery + Post-operative Chemo-Radiation | 13 (59%) |
Radiation | 1 (5%) |
Prior radiation dose (Gy) | Â |
Total (daily) dose range | 40-65 (1.5-2) |
Histology | Â |
Squamous cell carcinoma | 21 (95.5%) |
M1 case | 1 (4.5%) |
Regions of recurrence or metastases | Â |
Tongue | 7 (31.8%) |
Mandible | 5 (22.7%) |
Maxilla | 3 (13.6%) |
Maxillary sinus | 3 (13.6%) |
Soft palate | 2 (9.1%) |
Limited with lymph node | 1 (4.5%) |
Temporal muscle | 1 (4.5%) |
Clinical Stage | Â |
rT0N1M0 | 1 (4.5%) |
rT0N0M1 | 1 (4.5%) |
rT2N0M0 | 3 (13.6%) |
rT3N0M0 | 5 (22.7%) |
rT3N1M0 | 2 (9.1%) |
rT3N2M0 | 1 (4.5%) |
rT4N0M0 | 5 (22.7%) |
rT4N1M0 | 2 (9.1%) |
rT4N2M0 | 2 (9.1%) |